What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Psychiatry
The scientist’s investigation covers issues in Cannabinoid receptor, Cannabinoid, Endocannabinoid system, Neuroscience and Maternal deprivation.
His Cannabinoid receptor study is concerned with the larger field of Internal medicine.
His Cannabinoid research focuses on subjects like Anxiolytic, which are linked to GABAB receptor, GABAergic and Glutamatergic.
His Endocannabinoid system study integrates concerns from other disciplines, such as Developmental psychology, Promoter, Molecular biology, Cannabis and Gene isoform.
His work deals with themes such as Schizophrenia and Cannabinoid Receptor Modulators, which intersect with Neuroscience.
His Maternal deprivation research incorporates themes from Hippocampal formation, Sex characteristics, Corticosterone and Elevated plus maze.
His most cited work include:
- Endocannabinoid system and stress and anxiety responses. (389 citations)
- Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. (182 citations)
- Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression, and regulation by cannabinoid receptor ligands (146 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Endocrinology, Internal medicine, Endocannabinoid system, Cannabinoid receptor and Maternal deprivation.
His study looks at the relationship between Endocrinology and fields such as Agonist, as well as how they intersect with chemical problems.
In his study, which falls under the umbrella issue of Internal medicine, Spleen is strongly linked to Immune system.
Maria-Paz Viveros combines subjects such as URB597, Neuroscience, Amygdala, Fatty acid amide hydrolase and Energy homeostasis with his study of Endocannabinoid system.
His Cannabinoid receptor study combines topics in areas such as Cannabinoid, Pharmacology and Nicotine.
His Maternal deprivation research is multidisciplinary, incorporating elements of Elevated plus maze, Weight gain, Hippocampus and Endocrine system.
He most often published in these fields:
- Endocrinology (63.87%)
- Internal medicine (63.87%)
- Endocannabinoid system (34.45%)
What were the highlights of his more recent work (between 2014-2020)?
- Internal medicine (63.87%)
- Endocrinology (63.87%)
- Endocannabinoid system (34.45%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Endocrinology, Endocannabinoid system, Leptin and Neuroscience.
His studies deal with areas such as Gene expression and Traumatic brain injury as well as Internal medicine.
In general Endocrinology, his work in Adipose tissue, Hippocampal formation and Leptin Deficiency is often linked to Synaptophysin linking many areas of study.
His work deals with themes such as Cognition and Cannabinoid receptor, which intersect with Endocannabinoid system.
His work carried out in the field of Neuroscience brings together such families of science as Proinflammatory cytokine and Cannabinoid.
Maria-Paz Viveros has included themes like Weight gain and Hippocampus in his Maternal deprivation study.
Between 2014 and 2020, his most popular works were:
- Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol (71 citations)
- The maternal deprivation animal model revisited. (68 citations)
- The maternal deprivation animal model revisited. (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Endocrinology
- Psychiatry
Maria-Paz Viveros mainly investigates Neuroscience, Endocannabinoid system, Cannabinoid, Hippocampus and Neuroprotection.
In his study, Endocrinology is inextricably linked to Cannabinoid receptor type 2, which falls within the broad field of Endocannabinoid system.
His Cannabinoid research includes elements of Clozapine and Cannabidiol.
His research in Hippocampus intersects with topics in Maternal deprivation, Prefrontal cortex, Cognition, Leptin and Neuropsychiatry.
His Cannabinoid receptor study improves the overall literature in Agonist.
The subject of his Cannabinoid receptor type 1 research is within the realm of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
